Upgrade to SI Premium - Free Trial

PTC Therapeutics (PTCT) PT Lowered to $46 at RBC Capital

November 6, 2018 6:46 AM
RBC Capital analyst Brian Abrahams lowered the price target on ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS View Analyst PT Change

Next Articles